Titre:
  • Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium
Auteur:Van Wilder, Philippe; Pirson, Magali; Dupont, Alain
Informations sur la publication:European Journal of Clinical Pharmacology
Statut de publication:Publié, 2019
Sujet CREF:Pharmacologie
Mots-clés:Access
HTA
Innovation
Managed entry schemes
Medicinal products
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0031-6970
info:doi/10.1007/s00228-019-02665-6
info:pii/10.1007/s00228-019-02665-6
info:scp/85063066634
info:pmid/30877328